TRAMETINIB

trametinib 500 microgram tablet, 30

TRAMETINIB (11821E)

trametinib 500 microgram tablet, 30
11821E
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Resected Stage IIIB, Stage IIIC or Stage IIID malignant melanoma
Treatment phase: Initial treatment

Restriction

Indication: Resected Stage IIIB, Stage IIIC or Stage IIID malignant melanoma
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 3 Max qty units: 90 # of repeats: 3 DPMQ: $5,395.83 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Mekinist